Pfizer Inc
(MIL:1PFE)
€
25
-0.395 (-1.56%)
Market Cap: 140.28 Bil
Enterprise Value: 192.77 Bil
PE Ratio: 36.11
PB Ratio: 1.64
GF Score: 63/100 
Pfizer Inc at Citi BioPharma Conference Transcript
Sep 07, 2023 / 02:30PM GMT
Andrew Simon Baum
Citigroup Inc., Research Division - Global Head of Healthcare Research and MD
So delighted to introduce Mikael Dolsten. Mikael is President, R&D, Chief Scientific Officer. Did I miss any other title?
Mikael Dolsten
Pfizer Inc. - Chief Scientific Officer and President of Research & Development
You did it very well.
Andrew Simon Baum
Citigroup Inc., Research Division - Global Head of Healthcare Research and MD
That's it. And also Chris Stevo, the Head of IR; and then we have several other members of the Pfizer team with us today. So obviously, there's a lot of change going on -- oh, sorry, forgive me. Chris is going to make some opening comments. Then he's going to pass it to Mikael. Then I'll ask the question.
Christopher J. Stevo
Pfizer Inc. - Senior VP & Chief IR Officer
So this is going to be very scintillating and interesting for all of you. I can assure you of that. In the course of this presentation, Mikael might make some forward
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers